| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.481 | 8.208 | 9.533 | 5.965 | 709 | 3.613 |
| Total Income - EUR | - | - | - | - | 2.481 | 8.211 | 9.536 | 6.829 | 709 | 3.613 |
| Total Expenses - EUR | - | - | - | - | 272 | 2.243 | 4.401 | 4.412 | 1.299 | 3.810 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.210 | 5.968 | 5.135 | 2.417 | -589 | -197 |
| Net Profit/Loss - EUR | - | - | - | - | 2.135 | 5.722 | 4.843 | 2.212 | -589 | -260 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Endocrine Today S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 25 | 7.947 | 6.617 | 5.449 | 4.452 |
| Current Assets | - | - | - | - | 2.226 | 8.616 | 6.149 | 10.097 | 2.724 | 1.554 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 553 | 279 | 331 | 1.724 | 0 | 0 |
| Cash | - | - | - | - | 1.673 | 8.336 | 5.819 | 8.374 | 2.724 | 1.554 |
| Shareholders Funds | - | - | - | - | 2.177 | 7.858 | 10.505 | 2.185 | -130 | -389 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 74 | 1.088 | 3.737 | 14.707 | 8.553 | 7.014 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endocrine Today S.r.l.